GEODE CAPITAL MANAGEMENT, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 74 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$169,982
+31.6%
807,5170.0%0.00%
Q1 2023$129,202
+28739.7%
807,5170.0%0.00%
Q4 2022$448
-100.0%
807,517
-7.1%
0.00%
Q3 2022$1,034,000
+88.3%
869,5750.0%0.00%
Q2 2022$549,000
-66.4%
869,575
-39.3%
0.00%
Q1 2022$1,632,000
-55.6%
1,431,624
-12.3%
0.00%
Q4 2021$3,673,000
-38.1%
1,632,561
-5.9%
0.00%
-100.0%
Q3 2021$5,930,000
+40.2%
1,734,032
+22.6%
0.00%0.0%
Q2 2021$4,230,000
+90.4%
1,414,918
+105.6%
0.00%
Q1 2021$2,222,000
+173.6%
688,169
+79.6%
0.00%
Q4 2020$812,000
+86.7%
383,077
+3.0%
0.00%
Q3 2020$435,000
+29.5%
371,8600.0%0.00%
Q2 2020$336,000
+10.5%
371,860
+2.3%
0.00%
Q1 2020$304,000
-56.4%
363,617
-50.0%
0.00%
Q4 2019$698,000
+86.6%
727,234
+100.0%
0.00%
Q3 2019$374,000
-42.8%
363,6170.0%0.00%
Q2 2019$654,000
-1.7%
363,617
+2.7%
0.00%
Q1 2019$665,000
-20.3%
354,047
-50.0%
0.00%
Q4 2018$834,000
-13.0%
708,094
+100.0%
0.00%
Q3 2018$959,000
+46.2%
354,047
+3.0%
0.00%
Q2 2018$656,000
-4.0%
343,843
+5.6%
0.00%
Q1 2018$683,000
+3.5%
325,5670.0%0.00%
Q4 2017$660,000
+86.4%
325,567
+22.2%
0.00%
Q3 2017$354,000
-15.9%
266,503
-0.6%
0.00%
Q2 2017$421,000
-62.2%
268,198
-22.3%
0.00%
Q1 2017$1,114,000
+150.3%
345,366
+4.5%
0.00%
Q4 2016$445,000
-10.6%
330,361
+3.4%
0.00%
Q3 2016$498,000
+18.9%
319,410
+1.3%
0.00%
Q2 2016$419,000
-76.4%
315,401
-6.4%
0.00%
-100.0%
Q1 2016$1,774,000
-25.9%
336,935
+10.4%
0.00%0.0%
Q4 2015$2,394,000
-22.3%
305,057
-16.3%
0.00%
-50.0%
Q3 2015$3,080,000
-20.9%
364,678
+2.5%
0.00%0.0%
Q2 2015$3,896,000
-14.0%
355,894
+9.9%
0.00%
-33.3%
Q1 2015$4,528,000
-20.6%
323,971
-4.0%
0.00%0.0%
Q4 2014$5,701,000
+78.9%
337,641
+42.2%
0.00%
+50.0%
Q3 2014$3,187,000
+6.5%
237,494
+1.1%
0.00%0.0%
Q2 2014$2,993,000
+11.3%
234,971
+3.9%
0.00%0.0%
Q1 2014$2,689,000
-10.5%
226,159
+3.9%
0.00%0.0%
Q4 2013$3,006,000
-12.6%
217,727
+10.5%
0.00%
-33.3%
Q3 2013$3,439,000
+3.5%
197,096
-3.6%
0.00%0.0%
Q2 2013$3,323,000204,4630.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
BVF INC/IL 15,232,268$41,279,0003.63%
NORTHPOINTE CAPITAL LLC 528,739$1,433,0000.21%
Opaleye Management Inc. 275,000$745,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 364,401$988,0000.12%
EcoR1 Capital, LLC 462,068$1,252,0000.11%
PLATINUM INVESTMENT MANAGEMENT LTD 990,748$2,685,0000.08%
GSA CAPITAL PARTNERS LLP 284,354$771,0000.04%
Fosun International Ltd 358,859$879,0000.04%
Clear Harbor Asset Management, LLC 97,630$200,0000.04%
180 WEALTH ADVISORS, LLC 30,000$81,0000.04%
View complete list of INFINITY PHARMACEUTICALS INC shareholders